Is COVID-19 a New Hematologic Disease? - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Stem Cell Reviews and Reports Année : 2020

Is COVID-19 a New Hematologic Disease?

Résumé

SARS-CoV-2 viruses are positive single-stranded RNA viruses, whose infection can be asymptomatic or lead to the coronavirus disease 2019 (Covid-19). Covid-19 is a respiratory infection with a significant impact on the hematopoietic system and hemostasis leading to several cardiovascular complications. Hematologic consequences of this new infection allowed medical community to start new treatment approaches concerning infection going from targeted anti-inflammatory drugs to anticoagulation or stem cell therapies. A better understanding of Covid-19 pathophysiology, in particular hematological disorders, will help to choose appropriate treatment strategies.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée
Loading...

Dates et versions

inserm-02611228 , version 1 (18-05-2020)

Identifiants

Citer

Benjamin Debuc, David M Smadja. Is COVID-19 a New Hematologic Disease?. Stem Cell Reviews and Reports, 2020, Epub ahead of print. ⟨10.1007/s12015-020-09987-4⟩. ⟨inserm-02611228⟩

Collections

INSERM UP-SANTE
76 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More